Streptococcus suis serotype 2 is an extracellular encapsulated bacterium that causes severe septicemia and meningitis in swine and humans. Albeit crucial in the fight against encapsulated bacteria, the nature of the capsular polysaccharide (CPS)-specific antibody (Ab) response during S. suis type 2 infection is unknown. We compared for the first time the features of CPS-specific versus protein-specific Ab responses during experimental infections with live virulent S. suis type 2 in mice. The primary protein-specific Ab response was dominated by both type 1 and 2 IgG subclasses, whereas IgM titers were more modest. The secondary protein-specific Ab response showed all of the features of a memory response with faster kinetics and boosted the titers of all Ig isotypes. In contrast, the primary CPS-specific Ab response was either inexistent or had titers only slightly higher than those in noninfected animals and was essentially composed of IgM. A poor CPS-specific memory response was observed, with only a moderate boost in IgM titers and no IgG. Both protein-and CPS-specific Ab responses were Toll-like receptor 2 independent. By using S. suis type 2 strains of European or North American origin, the poor CPS-specific Ab response was demonstrated to be independent of the genotypic/phenotypic diversity of the strain within serotype 2. Finally, the CPS-specific Ab response was also impaired and lacked isotype switching in S. suis-infected pigs, the natural host of the bacterium. The better resistance of preinfected animals to reinfection with the same strain of S. suis type 2 might thus more likely be related to the development of a protein rather than CPS Ab response.
S
treptococcus suis is an encapsulated extracellular bacterium that causes severe septicemia with sudden death, meningitis, endocarditis, pneumonia, and arthritis in pigs and thus is responsible for important economic losses in the swine industry. It is also an emerging zoonotic pathogen in humans, with deadly outbreaks reported in Asian countries (1, 2) . Of the 35 capsular types described, type 2 is the most virulent and is frequently isolated from both swine and humans (3) . The capsular polysaccharide (CPS) is considered a critical virulence factor through its strong antiphagocytic effect (4) (5) (6) (7) . The structure of S. suis type 2 CPS is composed of the monosaccharides glucose, galactose, N-acetylglucosamine, and rhamnose arranged into a unique repeating unit that contains a side chain terminated by sialic acid (8) . Albeit there is a common CPS structure within serotype 2 strains, very distinct genotypic/ phenotypic differences are observed in subcapsular components in terms of the geographic origin of the strains, mainly between Eurasian and North American strains (3) .
Adaptive immunity to encapsulated extracellular bacteria is mediated largely by the humoral response (9, 10) . The efficacy of protection of the different immunoglobulin (Ig) classes during bacterial infection is dependent on the specificity and affinity with the targeted antigen and on their biological functions. In mice, IgG2b, IgG2c, and IgG3, called "type 1 IgG subclasses" because they are associated with gamma interferon (IFN-␥)-dominant Th1 immune responses, are particularly effective at mediating bacterial lysis by triggering the complement cascade directly at the surface of the pathogen or by favoring bacterial opsonophagocytosis (11) (12) (13) (14) . In contrast, IgG1 (called the "type 2 IgG subclass") elicited during interleukin-4 (IL-4)-dominant Th2 immune responses, usually has a less protective potential. Although the concept of type 1 or type 2 IgG subclasses is not well documented for pigs, recent studies have showed that porcine IgG2 had greater complement-activating capacity than IgG1 (15, 16) .
Even if both protein-and CPS-specific antibodies (Abs) are known to participate in protection against extracellular encapsulated bacteria (9, 10) , features of the Ab responses specific to these two different antigens have been mainly elucidated by studies using isolated, purified molecules. In contrast to the protein-specific response, the CPS-specific Ab response is more rapid, shows limited generation of memory or affinity maturation, and presents a more restricted Ig isotype profile (17) . However, the characteristics of the CPS-specific response to whole encapsulated bacteria, where CPS is associated with surface components of the bacteria, such as cell wall polysaccharides, proteins, and lipids, are not well known and seem to differ between pathogens. In vivo immunization experiments in mice have revealed that the primary CPSspecific Ab response against intact Streptococcus pneumoniae, Neisseria meningitidis, or group B Streptococcus (GBS) comprised IgM as well as all four IgG subclasses. However, kinetics of the response was faster with S. pneumoniae and GBS than with N. meningitidis. Moreover, in contrast to N. meningitidis and GBS, no memory anti-CPS IgG response was observed after a second immunization with S. pneumoniae (18) (19) (20) . Thus, it was proposed that differences in underlying subcapsular bacterial domains differentially regulate the CPS-specific Ab response (19, 20) . Nevertheless, killed (18) (19) (20) or nonlethal (21) doses of live bacteria were used in those studies, which did not allow conclusions to be drawn about the features of Ab responses during a clinical infection.
Previous reports have demonstrated that specific humoral response could play an important role in host survival to S. suis type 2 infection. Passive transfer with pig or rabbit hyperimmune sera allowed protection of pigs and mice against homologous S. suis type 2 challenge (22) (23) (24) . However, the specific contribution of Abs directed against CPS or other bacterial components in protection remains unclear. Others studies have shown that the CPS had, as an immunogen, high protective potential in the fight against infection by S. suis type 2. Mouse or pig polyclonal sera against S. suis type 2 CPS had a protective role in opsonophagocytosis in vitro assays (25) (26) (27) , and passive transfer of anti-S. suis type 2 CPS monoclonal Ab allowed mice to resist in vivo challenge (27) . However, the kinetics and nature of the anti-CPS or the anti-protein-specific response during S. suis clinical infection have never been characterized (28) .
Toll-like receptors (TLRs) play a crucial role in detecting the presence of pathogens and are important for the initiation of the immune response as well as the shaping of adaptive immunity (29) . Among TLRs, TLR2 is mainly involved in immune responses against cell wall components derived from Gram-positive bacteria (30) , but some experiments have demonstrated its role in immune responses against CPS as well (31-34). Whereas involvement of TLR2 in innate immune response against bacteria is well established (35, 36) , few studies have proven its participation in the adaptive humoral response. Immunization experiments of mice with glycoconjugate vaccine derived from Haemophilus influenzae established a role of the receptor in mediating both CPS-and protein-specific Ab responses (37) , and mice genetically deficient in TLR2 elicited lower protein-and CPS-specific type 1 IgG responses relative to control mice during primary and/or secondary immunizations with whole killed S. pneumoniae cells (18) .
Earlier reports have concluded that TLR2 plays a dominant role in the induction of innate immunity in response to S. suis type 2. In vitro interactions of the bacteria with mouse, swine, or human cells induced production of cytokines and chemokines and expression of costimulatory molecules and major histocompatibility complex class II in a TLR2-dependent manner (7, 38, 39) . Moreover, the in vivo contribution of TLR2 to the expression and production of cytokines and chemokines has been recently observed in a mouse model of S. suis type 2 experimental infection (40) . However, the contribution of TLR2 to the adaptive immunity and in particular to the humoral response against S. suis type 2 has never been studied. Several components from Gram-positive bacteria, such as lipoproteins, lipoteichoic acid, and CPS, are known to be perceived by TLR2 (33, 34, 41) and are expressed by S. suis type 2 (42) . Whereas chemokine production by murine DCs stimulated with highly purified S. suis type 2 CPS has been demonstrated to be partially TLR2 dependent (34) , the involvement of noncapsular antigens in S. suis type 2 recognition by TLR2 is still unknown, yet, recent studies have determined that cell wall components and lipoproteins may be such candidates (39, 43, 44) .
The main goal of this study was thus to evaluate for the first time the kinetics, magnitude, and isotype profile of CPS-specific Ab responses during primary and secondary experimental infections with live cells of virulent strains of S. suis type 2. In addition, the influence of distinct underlying subcapsular bacterial domains on the anti-CPS response was evaluated using two phenotypically very different serotype 2 strains. The features of the antiprotein responses were also analyzed and compared to those of the anti-CPS response. Finally, the involvement of TLR2 in the primary anti-S. suis adaptive response was evaluated using mice genetically deficient for this receptor. Features of the specific Ab responses obtained in mice were then compared to those obtained after experimental infection in pigs, the S. suis natural host.
MATERIALS AND METHODS
S. suis strains and growth conditions. Encapsulated S. suis type 2 strains P1/7 (45) and 89-1591 (46) , isolated from pigs with meningitis in Europe (United Kingdom) and North America (Canada), respectively, were used for experimental infections. A nonencapsulated ⌬cpsF mutant derived from P1/7 (5) and M2, derived from 89-1591 (46), were used as the coating for enzyme-linked immunosorbent assay (ELISA) evaluation of the noncapsular, mainly protein-specific Ab response (see below). Bacteria were grown as previously described (47) . Briefly, bacteria were grown overnight onto sheep blood agar plates at 37°C, and isolated colonies were cultured in 5 ml of Todd-Hewitt broth (THB [Becton Dickinson]) for 8 h at 37°C. Then, 10 l of 1/1,000 dilutions of 8-h cultures were transferred into 30 ml of THB and incubated for 16 h at 37°C. Stationary-phase bacteria were washed in phosphate-buffered saline (PBS [pH 7.3]). The bacterial pellet was then resuspended in vehicle solution and adjusted to the desired concentrations. Aliquots of the final bacterial suspension were plated using an Autoplate 4000 automated spiral plater (Spiral Biotech) onto sheep blood agar plates, and colonies were accurately counted after overnight incubation at 37°C.
Mice and experimental infections. Wild-type (WT) 5-week-old female C57BL/6J mice or TLR2 Ϫ/Ϫ (B6.129-Tlr2 tmlKir /J) mice from the Jackson Laboratory were acclimatized to standard laboratory conditions with free access to water and rodent chow. The study was conducted in accordance with the guidelines and policies of the Canadian Council on Animal Care and the principles set forth in the Guide for the Care and Use of Laboratory Animals by the Animal Welfare Committee of the University of Montreal. For the study of primary adaptive immune responses, WT and TLR2 Ϫ/Ϫ mice were infected with 1 ml of a suspension of 2 ϫ 10 7 CFU of live S. suis type 2 strain P1/7 cells administered by intraperitoneal (i.p.) injection on day 0. Negative-control mice were injected with vehicle solution (sterile THB). The optimal bacterial dose was determined in standardization pretrials in WT mice (data not shown) and based on previous studies with TLR2 Ϫ/Ϫ mice (40) . On days 7, 14, and 21 postinfection, mice were euthanized, and sera were collected and frozen at Ϫ80°C for ELISA Ig titration. For the study of memory adaptive immune responses, WT mice received an i.p. injection of 1 ml of a suspension of 2 ϫ 10 7 CFU of live S. suis type 2 strain P1/7 on day 0. Surviving mice were challenged i.p. with 1 ml of 5 ϫ 10 7 CFU on day 21. Negative-control mice were similarly injected with vehicle solution. Challenge control mice (no primary infection) received THB on day 0 and 1 ml of 5 ϫ 10 7 CFU on day 21. Mortality levels were recorded during the first week postchallenge. On days 28, 35, and 42, the surviving mice were euthanized, and sera were frozen after collection. In some experiments, primary and memory responses were evaluated in WT mice infected with live S. suis type 2 strain 89-1591 following the same protocol described above. ELISA Ig titration was performed from blood samples collected from the tail vein of each mouse. The numbers of animals included in the experimental groups are detailed in the figure legends.
Measurement of blood bacteremia and clinical parameters of disease in mice. Infected mice were monitored three times daily for mortality, clinical signs of systemic disease, such as rough hair coat, swollen/ closed eyes, ocular edema, hunchback, depression, lethargy, and clinical signs of meningitis, such as spatial disorientation, hyperexcitation, opisthotonos, or circular walking with the head toward one side. Blood bacterial loads were assessed in WT and TLR2 Ϫ/Ϫ mice by collecting a 5-l blood sample from the tail daily up to day 4 postinfection. Proper dilutions were plated, and bacterial numbers were counted as described above.
Pigs and experimental infection. Five-week-old Dutch Landrace pigs were purchased from porcine reproductive and respiratory syndrome virus-free herds from the Prairie Swine Center, University of Saskatchewan. The herd was considered free from endemic diseases caused by S. suis. Serotype 2 S. suis could not be detected by PCR from nasal swabs of any of the animals used (48) . The study was conducted in accordance with the ethical guidelines of the University of Saskatchewan and the Canadian Council of Animal Care. One hour after the nasal cavity was treated with a 1% acetic acid solution, animals were infected intranasally with 2 ml equivalent to 4 ϫ 10 9 CFU of live S. suis strain 89-1591. Negative-control pigs were administered a vehicle solution (sterile PBS). The optimal route of infection and bacterial dose were determined in standardization pretrials (data not shown). Clinical signs (fever, attitude, locomotion, and lameness) and mortality were monitored throughout the experiment. On days 7, 21, and 35 postinfection, a serum sample was collected from each animal and frozen at Ϫ80°C for ELISA Ig titration. The animals were euthanized on day 35 postinfection. The numbers of animals included in the experimental groups are detailed in the figure legends.
Titration of protein-and CPS-specific Abs of mice and pigs. Specific Ab titers were determined by indirect ELISA as described below.
(i) Titration of protein-specific Abs. Polysorb immunoplates (Nunc) were coated at 100 l/well with nonencapsulated ⌬cpsF or M2 mutant (10 7 CFU/ml in water) for titration of Abs in animals infected with strains P1/7 and 89-1591, respectively. Albeit a response to other cell wall components might be detected, proteins are the dominant antigens present at the surface of nonencapsulated mutants, and thus the detected response in the ELISA is labeled "antiprotein" throughout the study for simplicity. Plates were dried during 2 days, and 50 l per well of 100% methanol was added. After evaporation of methanol, plates were stored at room temperature (RT) until utilization. For titration of pig Abs, after washes with PBS containing 0.05% Tween 20 (PBS-T), the plates were blocked with 2% skim milk in PBS-T for 1 h at RT. Mouse or pig sera were then serially diluted (2-fold) in PBS-T (starting with a dilution of 1/50) and incubated for 1 h at RT. Plates were then washed in PBS-T. For titration of mouse Abs, plates were incubated with peroxidase-conjugated goat anti-mouse total Ig (IgG plus IgM) (Jackson ImmunoResearch), IgM, IgG1, IgG2b, IgG2c, or IgG3 (Southern Biotech) Abs for 1 h at RT. For titration of pig total Ig (IgG plus IgM) or IgM, plates were incubated with peroxidaseconjugated goat anti-pig total Ig (IgG plus IgM) (Jackson ImmunoResearch) or IgM (Serotec) Abs for 1 h at RT. For pig IgG1 or IgG2 detection, mouse anti-pig IgG1 or IgG2 (Serotec) was added for 1 h at RT. After washing, peroxidase-conjugated goat anti-mouse IgG (Serotec) Abs were added for 1 h at RT. Plates were developed with 3,3=,5,5=-tetramethylbenzidine (TMB) substrate, and the enzyme reaction was stopped by addition of 0.5 M H 2 SO 4 . Absorbance was read at 450 nm with an ELISA plate reader. The reciprocal of the last serum dilution that resulted in an optical density at 450 nm (OD 450 ) of Յ0.2 (cutoff) was considered the titer of that serum. When the OD 450 of the first dilution of a serum was lower than the cutoff, its titer was arbitrarily fixed to 50.
(ii) Titration of CPS-specific Abs. Polysorb immunoplates were coated with highly purified CPS produced as previously described from S. suis type 2 reference strain S735 (ATCC 43765) (34) . A solution of 2 g/ml of CPS in carbonate buffer (0.1 M [pH 9.6] at 100 l/well) was added overnight at 4°C. Free sites were then blocked for 1 h at RT with 1% bovine serum albumin (BSA) in PBS or 2% skim milk in PBS-T before addition of mouse or pig serum dilutions, respectively. CPS-specific Ab titers were determined as described above.
To control interplate variations, we added an internal reference positive control to each plate. For titration of mouse Abs, this control was a pool of sera from mice hyperimmunized with 10 9 CFU of killed S. suis type 2 in TiterMax Gold adjuvant (Sigma). For titration of pig Abs, this control was a serum of a pig hyperimmunized with 10 8 CFU of live S. suis type 2 strain 89-1591. The reaction in TMB was stopped when an OD 450 of 1 was obtained for the positive control. Optimal dilutions of the coating antigen (bacteria or CPS), the positive internal control sera, and the peroxidaseconjugated anti-mouse or anti-pig Abs were determined during preliminary standardizations.
Statistical analysis. Ab titer data were analyzed for significance using analysis of variance (ANOVA). The Kaplan-Meier method and log-rank Mantel-Cox tests were used to compare the survival rates of the studied groups. Correlation analyses were performed by the Spearman test. All analyses were done using the Sigma Plot system (v11.0; Systat Software). A P value of Ͻ0.05 was considered statistically significant.
RESULTS

Different features of protein-and CPS-specific Ab responses of WT mice after primary infection with S. suis type 2.
In the first set of experiments, we infected WT mice (n ϭ 62) with S. suis type 2 European strain P1/7 to examine the features of the antiprotein and anti-CPS humoral responses specific to an intact, live extracellular bacteria. As shown in Fig. 1A , mortality of 40% was observed during the first 3 days postinfection and was associated with clinical signs of sepsis. The appearance of clinical signs of meningitis was observed in 14% of the remaining infected mice between days 3 and 7 postinfection. The disease evolution was thus similar to that in previous studies (40, 47, 49) . Blood bacterial loads were determined on days 1, 2, 3, and 4 postinfection. Bacteremia levels remained high between days 1 and 3 and started to decrease on day 4 postinfection (Fig. 1B) .
The surviving mice were evenly distributed into three groups and euthanized on days 7, 14, and 21 postinfection for titration of specific serum Abs. This distribution was made based on bacteremia levels. That is mice with different levels of bacteremia were randomly euthanized at each time point to avoid interference of this parameter with kinetics of Ab levels. To study the potential differences in the characteristics of CPS-and protein-specific Ab responses to whole S. suis type 2, we have chosen purified CPS and the whole nonencapsulated mutant of S. suis type 2 as representative target antigens. As shown in Fig. 2 , there was a significant induction of total Ig (IgG plus IgM) antiprotein response in infected mice as soon as day 7 postinfection, and this response increased over time until day 21 (P Ͻ 0.05 in comparison with day 7). When the nature of the different Ig isotypes and IgG subclasses induced by primary S. suis infection was explored in more detail, a weak antiprotein IgM response was observed. In contrast, a significant increase in IgG1, IgG2b, and IgG2c antiprotein titers was observed in infected versus noninfected mice. Finally, levels of IgG3 were also significantly higher than those of controls, yet titers were slightly lower than those of the other three IgG subclasses. Kinetics analysis showed that Ig class switching occurred early after infection, and the levels of the different IgG subclasses remained high over the 3-week period.
Concerning CPS-specific Ab response (Fig. 3) , infected mice presented a very weak increase in total Ig (IgG plus IgM) titers in comparison with noninfected mice on day 14, and titers decreased on day 21 postinfection. Moreover, the magnitude of the total Ig (IgG plus IgM) anti-CPS response in infected mice was 2 logs fewer than that of the antiprotein counterpart. Indeed, whereas there was a 400-fold difference in peaks of total Ig (IgG plus IgM) antiprotein titers between infected mice and noninfected mice, an only 4-fold difference in CPS-specific Ab titers was observed between the two mouse groups. Finally, in terms of the difference of the protein-specific response, the CPS-specific response in infected mice was mainly composed of IgM, whose kinetics and magnitude were similar to those of the total Ig (IgG plus IgM) anti-CPS response, as neither IgG1, IgG2b, IgG2c, nor IgG3 was detected between days 7 and 21 postinfection (results not shown).
We also investigated if there was a correlation between Ab titers and bacteremia. Interestingly, there was a positive correlation between total Ig (IgG plus IgM) antiprotein titers from day 7 to day 21 and bacteremia obtained on day 1 postinfection (Fig. 4 and Table 1 ). Similar results were obtained when bacteremia was correlated with the total Ig (IgG plus IgM) antiprotein titers of days 7, 14, or 21 taken separately. A positive correlation with bacteremia was obtained at 6, 12, and 48 h postinfection as well (data not shown). No correlation was found between anti-CPS Ab titers and bacteremia (data not shown).
In order to evaluate if the features of the anti-CPS Ab response observed during infection with S. suis type 2 strain P1/7 were specific to this strain or represented a more global pattern of serotype 2, we conducted experimental infections with S. suis type 2 North American strain 89-1591 in WT mice. Mortality of 50% was observed during the first week postinfection and was associated with clinical signs of sepsis or meningitis (Fig. 5A ). High and globally homogenous blood bacteremia levels were detected in surviving mice during the first 2 days postinfection and then decreased on day 3 postinfection (Fig. 5B ). There was a significant induction of total Ig (IgG plus IgM) antiprotein response in mice as soon as day 7 and until day 21 postinfection. This response was composed of low levels of IgM and high levels of both the type 1 and 2 IgG subclasses, as shown for strain P1/7 ( Fig. 5C ) (data not shown). In contrast to the antiprotein Ab response and similar to what was shown after the P1/7 infection, we obtained very low IgM or IgG anti-CPS titers between days 7 and 21 postinfection (Fig. 5D) . Thus, the low levels of CPS-specific Ab response observed after S. Ϫ/Ϫ (n ϭ 50) mice after primary intraperitoneal infection with 2 ϫ 10 7 CFU of live S. suis serotype 2 strain P1/7 was monitored for 7 days. *, statistically significant differences (P Ͻ 0.05) between the WT and TLR2 Ϫ/Ϫ mouse groups, as determined by log-rank (Mantel-Cox) test. (B) Blood bacterial loads of WT (n ϭ 39) and TLR2 Ϫ/Ϫ (n ϭ 34) surviving mice after primary intraperitoneal infection with 2 ϫ 10 7 CFU of live S. suis serotype 2 strain P1/7 were determined on day 1, 2, 3, or 4 postinfection. Data from individual mice are presented, including the geometric mean with 95% confidence interval.
suis type 2 primary infection in mice seem to be independent of the bacterial strain used.
Poor memory CPS-specific Ab response of WT mice after secondary infection with S. suis type 2. In a second set of experiments, we aimed to determine the characteristics of specific Ab responses after secondary infection with S. suis type 2. WT mice were infected with 2 ϫ 10 7 CFU/ml of S. suis type 2 strain P1/7, and the surviving mice were challenged 3 weeks later with 5 ϫ 10 7 CFU/ml of the same strain. One day before challenge infection, total Ig (IgG plus IgM) antiprotein and anti-CPS Abs were titrated from blood samples collected from the tail. (This procedure does not require mouse euthanasia.) The titers were similar to those obtained on day 21 during the first set of experiments described above (data not shown). As shown in Fig. 6 , mice preinfected with S. suis type 2 showed a significant increase in resistance to a second infection (mortality of 23%) in comparison with control mice (mortality of 70%). Of mice surviving challenge infection, 27, 26, and 26 mice were euthanized for titration of specific serum Abs on days 28, 35, and 42, respectively. As shown in Fig. 2 , the secondary protein-specific Ab response to S. suis type 2 in challenged mice showed features of a memory response. Indeed, titers of total Ig (IgG plus IgM), IgM, and all four IgG subclasses were induced more rapidly than after primary infection, with a peak on day 28 (that is only 1 week postchallenge infection). Moreover, at this time, the levels of the total Ig (IgG plus IgM), IgM, and IgG subclasses were 10-to 20-fold higher than those obtained during the primary response and remained significantly higher up to day 42.
Concerning the CPS-specific Ab response after secondary infection, total Ig (IgG plus IgM) titers of infected mice peaked on day 28 and remained constant up to day 42 in challenged mice (Fig. 3 ). An approximately 2-fold increase was observed between primary and secondary total Ig (IgG plus IgM) anti-CPS titers. However, this secondary response was only constituted of IgM, which had the same kinetics and magnitude as the secondary total Ig (IgG plus IgM) anti-CPS response (Fig. 3) . Indeed, neither type 1 nor type 2 anti-CPS IgG subclasses could be detected from days 28 to 42 in challenged mice. Similarly, whereas the secondary protein-specific Ab response to S. suis type 2 strain 89-1591 presented a faster kinetics with boosted titers of both IgM and type 1 and 2 IgG subclasses, the secondary CPS-specific Ab response showed only a moderate boost in IgM titers with no isotypic switching ( Fig. 5C and D 
) (data not shown).
Role of TLR2 in protein-and CPS-specific Ab responses after infection with S. suis type 2. To evaluate the role of TLR2 in specific humoral responses against S. suis type 2, mice (n ϭ 50) genetically deficient for this receptor were infected with S. suis type 2 strain P1/7 in parallel to the studies with WT mice described above. Mortality of 24% was observed during the first 4 days postinfection and was associated with clinical signs of sepsis. The appearance of clinical signs of meningitis was observed in 16% of the remaining infected mice between days 6 and 7 postinfection. The absence of TLR2 improved protection against S. suis type 2 infection early during infection (until 5 days postinfection) as statistically better survival was observed in TLR2 Ϫ/Ϫ versus WT mice (Fig. 1A) . There was no statistical difference in bacterial loads between WT and TLR2 Ϫ/Ϫ mice 1, 2, 3, or 4 days postinfection (Fig. 1B) . These results are in accordance with a previous study (40) . Based on bacteremia levels, surviving TLR2 Ϫ/Ϫ mice were evenly distributed in three groups and euthanized on days 7, 14, and 21 postinfection for titration of specific serum Abs. Overall the nature of the protein-specific Ab response in TLR2 Ϫ/Ϫ mice was similar to the observed response in WT mice in terms of Ab levels, kinetics, and isotype switching (see Fig. S1A in the supplemental material).
Concerning the CPS-specific Ab response in TLR2 Ϫ/Ϫ mice, the overall response was similar to that observed in WT mice, with a weak total Ig (IgG plus IgM) response mainly composed of IgM as any of the four IgG subclasses could be measured from days 7 to 21 in TLR2 Ϫ/Ϫ mice. No statistical difference in CPS-specific Ab response was observed between WT and TLR2 Ϫ/Ϫ mice during the infection time (see Fig. S1B in the supplemental material).
As no role of TLR2 was observed during the course of a primary 
S. suis infection, the memory response was not evaluated in TLR2
Ϫ/Ϫ mice. The CPS-specific Ab response after primary infection with S. suis type 2 is also impaired in the natural host, the pig. In a last set of experiments, we aimed to determine if features of protein-and CPS-specific Ab responses to S. suis type 2 infection in mice were similarly observed in swine, the natural host of the bacterium. Toward this aim, pigs (n ϭ 13) were experimentally infected with S. suis type 2 strain 89-1591. Most animals developed fever. More than 60% of animals showed locomotion impairment, and 30% of animals died or had to be euthanized due to very high clinical scoring. Blood samples were collected from 9 surviving infected pigs on days 7, 21, and 35 postinfection for titration of specific Abs in serum. As shown in Fig. 7 , there was an increase in total Ig (IgG plus IgM) antiprotein titers on day 21 in infected versus noninfected pigs, which remained statistically higher up to day 35 postinfection. This response was composed of both IgG1 and IgG2 subclasses, with a significant increase compared to that in noninfected pigs on days 21 and 35, respectively. No antiprotein-specific Ab of the IgM isotype was observed in infected pigs. It should be noted that a high nonspecific IgM background was observed in placebo-administered (control) pigs. This background is probably due to cross-reactions with proteins expressed in non-serotype 2 S. suis strains or other species of streptococci probably present in the upper respiratory tract of these animals. Yet, the presence of cross-reactive proteins in the herd (and thus of potential crossreactive memory B cells) does not seem to influence the features of the anti-protein Ab responses against S. suis type 2, as antiprotein IgG responses took at least 21 days before reaching significant titers compared to controls. This kinetics better embodies a primary response than a memory response.
Concerning CPS-specific Ab response, a statistically significant induction of total Ig (IgG plus IgM) titers was observed in infected pigs on day 35 (Fig. 8) . However, the magnitude of this response was very weak compared to that of noninfected animals, and neither IgG1 nor IgG2 could be detected. Indeed, this weak anti-CPS Ab response was mainly composed of the IgM isotype.
DISCUSSION
Humoral immunity is largely known to be the main mechanism of adaptive immunity for host protection against infections with extracellular bacteria. Via their biological functions of opsonophagocytosis and/or opsonolysis, specific Abs allow clearance of bacteria by the innate immune system. This is the rationale for the development of vaccines effective against S. pneumoniae, N. meningitidis, and H. influenzae infections in humans. a Putative functions of the mouse/pig immunoglobulin (sub)classes against bacterial infections. CA, complement activation; OP, opsonophagocytosis; ϩϩ, strong activity; ϩ/Ϫ, weak/no activity. b Mice were infected i.p. with P1/7 at 2 ϫ 10 7 CFU for the primary infection and 5 ϫ 10 7 CFU for the secondary infection or 89-1591 at 2 ϫ 10 7 CFU for the primary infection and 5 ϫ 10 7 CFU for the secondary infection. Pigs were infected intranasally with 89-1591 at 4 ϫ 10 9 CFU (primary infection only). In each case, the titer represents the geometric mean of titers (10 3 ) at the peak of the corresponding response, and r represents the correlation coefficient of titers at the peak of the corresponding response with bacteremia obtained 1 day postinfection, as determined by Spearman rank order correlation (P Ͻ 0.05). Correlation studies were done only with the mouse model. NC, no correlation; NS, nonsignificant in comparison with titers from noninfected animals as determined by ANOVA; ND, not determined. c Data are for the IgG2 subclass. S. suis is one of the most important bacterial causes of septicemia and meningitis in swine worldwide. Moreover, due to an increase in the incidence and severity of S. suis infections in humans during the last decade, this pathogen is considered an important threat to human health, especially in Asia. However, no efficient vaccine against this extracellular bacterium is currently available. The vaccines used in the field are whole-cell killed bacterins, and they provide limited protection. Live nonvirulent mutants have been used with contradictory results (50) . Although protein subunit vaccine candidates have been proposed, the high phenotypic and genotypic variation among strains in different parts of the world may preclude their use.
Host protection against infection caused by S. suis is known to be mediated primarily by opsonophagocytosis/killing (27, (51) (52) (53) . Whereas published studies have evidenced the essential contribution of specific humoral immunity to the fight against S. suis (22) (23) (24) (25) (26) (27) 54) , no study has focused on the precise characteristics of protein-and CPS-specific responses after an infection with live S. suis ) or IgM antiprotein or anti-CPS titers were determined by ELISA on days 7 (n ϭ 9), 14 (n ϭ 7), and 21 (n ϭ 7) in surviving mice. In a second set of experiments targeting the secondary response, WT mice were infected with 2 ϫ 10 7 CFU of live S. suis serotype 2 strain 89-1591, and the surviving mice were challenged on day 21 with 5 ϫ 10 7 CFU of the same strain. Antiprotein or anti-CPS Ab titers of postchallenge surviving mice were determined by ELISA on days 28 (n ϭ 8), 35 (n ϭ 8), and 42 (n ϭ 7). "C Ϫ " represents a pool of control mice (n ϭ 3) injected with vehicle solution (THB), whose titers were evaluated on days 7, 14, 21, 28, 35, and 42. Data from individual mice are presented, including the geometric mean with 95% confidence interval. An arrow indicates secondary infection. *, statistically significant difference (P Ͻ 0.05) in comparison to C Ϫ ; #, statistically significant differences (P Ͻ 0.05) in comparison to the peak of the primary response. type 2. Our study is thus the first to describe in details the kinetics, magnitude, and isotype composition of protein-and CPS-specific Ab responses after primary and secondary infections with virulent strains of S. suis type 2. First, we have conduced experimental infections in mice, since the mouse model is well known to reproduce the clinical characteristics of infection observed in pigs (47, 49, 55) . The protein-specific Ab response to S. suis type 2 showed typical features of a T cell-dependent response, similarly to what was observed after immunization with intact S. pneumoniae, N. meningitidis, and GBS cells (18) (19) (20) . Indeed, the primary response was dominated by the IgG isotype, including both type 1 and 2 IgG subclasses, whereas IgM titers were more modest. The secondary IgG response showed all features of a memory response, with faster kinetics and 10-to 20-fold-boosted titers of IgM and all four IgG subclasses. At the opposite end of the protein-specific response, the CPS-specific Ab response to S. suis type 2 showed features of a T cell-independent response. The primary CPS-specific Ab response was either nonexistent or had titers only slightly higher than those of the noninfected animals and was essentially composed of IgM. A modest memory anti-CPS IgM response was observed in S. suis-infected mice, yet no isotype switching was observed (see Table 1 for a summary). In contrast to our observations, other studies noticed an induction of CPS-specific IgG response after mouse immunization with killed S. pneumoniae, N. meningitidis, and GBS cells (18) (19) (20) . Whereas the kinetics was faster after immunization with S. pneumoniae and GBS in comparison with N. meningitidis, the primary CPS-specific IgG response against the three bacteria was composed of both type 1 and type 2 IgG subclasses, with titers in the same range as those observed for the protein-specific IgG response (18) (19) (20) . Moreover, a memory CPS-specific IgG response was observed after a second immunization with N. meningitidis and GBS, with faster kinetics and higher titers than during primary exposure to those pathogens. Differences in the features of CPS-specific Ab response directed against whole S. pneumoniae, N. meningitidis, GBS, and S. suis cells can be explained first by differences in immunostimulatory properties intrinsic to CPS due to differences in the biochemistry of CPS (56), such as variations in the structure (57, 58), (60), and ability to bind to specific receptors (61) (62) (63) . The presence of sialic acid may also have a potential impact as this sugar is well known to interfere with the immune system by molecular mimicry and inhibition of complement activation (64, 65) and/or by interaction with the inhibitory CD22 receptor on B cells (66) . It should be noted that in GBS CPS, sialic acid is ␣2,3 linked to adjacent galactose, but in S. suis, CPS is found in the ␣2,6 linkage (34). CD22 binding affinity is ␣2,6 dependent. In this regard, no difference in primary and secondary CPS-specific IgG responses was observed after mouse immunization with mutant strain of GBS type III expressing desialylated CPS or with the WT strain (20) . The different dynamics of infection in the mouse models used for each pathogen can also account for the observed differences.
In addition to CPS itself, it has been suggested that differences observed in CPS-specific Ab responses between encapsulated bacteria are due to variations in the underlying subcapsular bacterial domains when mice are immunized with killed bacteria (20) . Our work used a clinical infection with live bacteria instead of killed bacteria, and thus our model also takes into account the influence of secreted components as well as antigens selectively expressed in vivo, which might have immunomodulatory properties. In this context, we have observed that CPS-specific Ab responses after mouse infection with two different virulent strains of S. suis type 2 present similar features with a primary response characterized by low or absent Ab titers, the absence of an isotypic switch, and a low or absent memory response (Table 1) .
Interestingly, the characteristics of the primary S. suis CPSspecific Ab response observed in pigs were very similar to those obtained in mice, although the pigs presented lower Ab titers (Table 1). Differences in the injection methods of the bacteria between mouse and pig models might have affected the kinetics of the Ab responses; however, the influence of the experimental administration route of S. suis on the humoral response has never been evaluated. Whereas the swine protein-specific response was mainly composed of both IgG1 and IgG2 subclasses, indicating a clear isotype switching, as observed in mice, the CPS-specific Ab response was extremely low and characterized by the lack of isotype switching. Similarly to our study, very weak total Ig (IgG plus IgM) anti-CPS titers could be detected after primary as well as secondary infection of pigs with live virulent European reference strain S735 of S. suis type 2 (28) . Thus, the present study suggests that the in vivo CPS-specific Ab response to virulent S. suis type 2, in both mice and pigs, is independent of the genotypic/phenotypic diversity of the strain used during infection. In other words, concerning S. suis strains within serotype 2, the features of the Ab response specifically directed against CPS are not influenced by the composition and/or architecture of the bacterial subcapsular domain. In the light of this observation, it is very noteworthy that no primary CPS-specific Ab response was observed in mice after clinical infection with a live virulent strain of S. suis serotype 14, which also possesses an ␣2,6-sialylated CPS (data not shown). These observations are in accordance with previous studies reflecting the poor immunogenic nature of S. suis type 2 CPS. In vitro studies using either nonencapsulated mutants or highly purified S. suis type 2 CPS have shown that this molecule severely interferes with the activation of the host innate immune system (5-7, 34, 39, 67) . In vivo immunization experiments in pigs showed that repeated injections of purified CPS (25) or whole killed S. suis type 2 cells (26, 68, 69) resulted in no or very low induction in CPS-specific Ab titers in comparison with proteinspecific Ab titers. TLR2 has been implicated as an important innate recognition receptor for S. suis type 2, and both in vitro and in vivo studies have highlighted its role in induction of an inflammatory response (38) (39) (40) . Thus, the better protection observed in TLR2 Ϫ/Ϫ mice is likely due to a reduction of the inflammatory response (40) . As TLRs have also been implicated in the regulation of proteinand/or CPS-specific Ab responses during immunization with encapsulated bacteria (18, 19) , we aimed to analyze its implication in the development of specific humoral response against S. suis type 2. No effect of TLR2 was observed in protein-specific or CPSspecific Ab responses after primary infection with S. suis type 2. Comparable with our results, no difference in IgG titers directed against whole-protein extract was observed between WT and TLR2 Ϫ/Ϫ mice after infection with Borrelia burgdorferi (70) . Whereas TLR4 was implicated in a CPS-specific IgG or IgM response to killed N. meningitidis, no implication of TLR2 was observed (19) . On the other hand, even if TLR2 played only a modest role in CPS-specific IgM response to immunization with killed S. pneumoniae cells, its presence was crucial for the development of CPS-specific IgG type 1 response (18) . The absence of implication of TLR2 in specific humoral response to S. suis type 2 could be explained, at least in part, by the fact that the levels of expression of splenic IFN-␥ and interleukin-6 (IL-6), known to be critical in promoting type 1 and type 2 adaptive immune responses (71, 72) , were either similar or only partially reduced in TLR2 Ϫ/Ϫ versus WT mice (40) . Implication of other receptors in the specific Ab response to S. suis, including members of the large family of lectin receptors, which are susceptible to recognizing the CPS of the bacteria (61, 62) , needs further investigations.
Finally, we have observed that preinfected mice showed significantly better resistance to a reinfection with the same strain of S. suis type 2 in comparison with non-preinfected mice. Even if a clear protective role of mouse or pig anti-S. suis type 2 CPS Abs had been demonstrated in opsonophagocytosis in vitro assays (25) (26) (27) , the weak CPS-specific Ab response induced after S. suis clinical infection seems to suggest that the protection observed in our study is more likely due to a protein-specific Ab response. Studies with the purified S. suis protein Sao have shown that the protective capacity of the humoral response against S. suis infection was dependent on the IgG subclass. Indeed, when the immunization protocol was changed with a vaccine formulation inducing bias toward a Th1-like immune response, dominated by the IgG2a response in mouse or IgG2 response in pigs, efficient immunity was conferred (16, 73) . In this regard, it is interesting to point out that all of the Th1 IgG subclasses are induced after primary and secondary infection with S. suis, yet, further functional assays of CPS-and protein-specific Abs are required for a better comprehension of their respective contributions to the fight against S. suis infection. A contributing role of cellular immunity to the whole protective response against this bacterium cannot be excluded.
In conclusion, the challenge in future vaccine design against S. suis resides in finding a protein or proteins able to overcome the phenotypic variability of S. suis type 2 strains worldwide or to render the CPS immunogenic, as if produced, anti-CPS Abs are probably highly protective against all S. suis type 2 strains.
